aTyr Pharma, Inc

(NASDAQ:LIFE)

Latest On aTyr Pharma, Inc (LIFE):

Date/Time Type Description Signal Details
2023-05-10 04:27 ESTNewsaTyr Pharma GAAP EPS of -$0.29N/A
2023-03-11 01:11 ESTNewsaTyr Pharma, Inc. (LIFE) Q4 2022 Earnings Call TranscriptN/A
2023-03-09 18:48 ESTNewsaTyr Pharma GAAP EPS of -$0.26 beats by $0.22, revenue of $10.4M beats by $10.15MN/A
2023-02-09 12:24 ESTNewsaTyr Pharma: The Uncertainty Of Efzofitimod, Analysis Of Clinical StudyN/A
2023-02-09 12:24 ESTNewsaTyr Pharma stock dips after pricing $50M stock offeringN/A
2023-02-08 23:11 ESTNewsaTyr pharma falls 10% on public offering of sharesN/A
2023-02-06 19:29 ESTNewsaTyr gains as late-stage study for lead asset brings $10M paymentN/A
2023-01-18 08:45 ESTNewsATyr Pharma therapy for lung disorder gets orphan drug status in EUN/A
2022-11-11 12:37 ESTNewsaTyr Pharma, Inc. (LIFE) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 19:11 ESTNewsaTyr Pharma GAAP EPS of -$0.46 in-lineN/A
2022-09-29 12:03 ESTNewsaTyr Pharma rises on U.S. patent for anti-neuropilin-2 monoclonal antibodiesN/A
2022-09-13 13:35 ESTNewsaTyr Pharma stock rises on FDA fast track status for efzofitimod for lung diseaseN/A
2022-08-17 03:35 ESTNewsaTyr pharma stock rises 15% after Q2 results; efzofitimod phase 3 trial enrollment on trackN/A
2022-08-16 10:03 ESTNewsaTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-15 17:44 ESTNewsaTyr Pharma GAAP EPS of -$0.44 in-lineN/A
2022-08-12 21:26 ESTNewsaTyr Pharma Q2 2022 Earnings PreviewN/A
2022-08-11 11:44 ESTNewsaTyr Pharma gains with FDA Fast Track status for lead assetN/A
2022-05-25 19:32 ESTNewsaTyr Pharma (LIFE) Investor presentations - SlideshowN/A
2022-05-21 08:31 ESTNewsaTyr Pharma ATS Conference Presentation May 2022N/A
2022-05-19 04:44 ESTNewsaTyr Pharma stock dips after Piper Sandler cuts price target on lung disease drug approval timelineN/A
2022-05-10 08:27 ESTNewsaTyr Pharma GAAP EPS of -$0.44 misses by $0.11N/A
2022-05-10 08:27 ESTNewsaTyr Pharma, Inc. (LIFE) CEO Dr. Sanjay S. Shukla on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-08 18:29 ESTNewsaTyr Pharma Q1 2022 Earnings PreviewN/A
2022-04-13 04:42 ESTNewsaTyr Pharma up 5% after hours following Orphan Drug Status for efzofitimodN/A
2022-03-16 04:24 ESTNewsaTyr Pharma files for $200M mixed shelf offeringN/A
2022-03-15 05:38 ESTNewsaTyr Pharma GAAP EPS of -$0.31 misses by $0.03N/A
2022-03-15 05:38 ESTNewsaTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-12 08:07 ESTNewsaTyr Pharma Q4 2021 Earnings PreviewN/A
2022-03-10 18:13 ESTNewsaTyr Pharma to begin registrational trial for lead asset in Q3 2022N/A
2022-01-13 17:18 ESTNewsaTyr Pharma's lung disease drug ATYR1923 named efzofitimodN/A
2022-01-06 14:37 ESTNewsaTyr Pharma's ATYR1923 an Orphan Drug in U.S. for sarcoidosisN/A
2021-12-28 10:10 ESTNewsaTyr Pharma: Successful Proof Of Concept In Pulmonary SarcoidosisN/A
2021-11-11 08:33 ESTNewsaTyr Pharma EPS beats by $0.15N/A
2021-11-11 08:33 ESTNewsaTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 11:00 ESTNewsaTyr Pharma Q3 2021 Earnings PreviewN/A
2021-09-25 05:18 ESTNewsaTyr Stock Is Buoyant On Highly-Promising Lung Disease Data - Wait For Hype To Die Down And BuyN/A
2021-09-25 05:18 ESTNewsaTyr Pharma posts biggest intraday loss in over two years after capital raiseN/A
2021-09-21 23:01 ESTNewsaTyr Pharma rises after success for lead asset in trial for lung diseaseN/A
2021-09-21 22:58 ESTNewsaTyr reaches a historic high after success in lung cancer study; Roth raises price targetN/A
2021-09-21 22:55 ESTNewsaTyr Pharma shares under pressure after proposed capital raiseN/A
2021-09-21 22:55 ESTNewsaTyr Pharma plunges on proposed stock offeringN/A
2021-09-21 22:54 ESTNewsaTyr Pharma prices $75M capital raiseN/A
2021-09-21 22:51 ESTNewsTang Capital Partners discloses 6.3% stake in aTyr PharmaN/A
2021-09-21 22:48 ESTNewsaTyr Pharma closes $86.3M underwritten public offeringN/A
2021-08-11 03:39 ESTNewsaTyr Pharma EPS misses by $0.15N/A
2021-08-11 03:38 ESTNewsaTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-29 21:13 ESTNewsaTyr Pharma granted U.S. patent covering use of ATYR1923 in lung inflammationN/A
2021-07-21 13:49 ESTNewsaTyr pharma records last patient visit in early-stage ATYR1923 pulmonary sarcoidosis trialN/A
2021-04-10 00:29 ESTNewsaTyr Pharma posts preclinical research of ATYR2810 in lung and breast cancer at AACR21N/A
2021-03-24 01:56 ESTNewsaTyr Pharma EPS beats by $0.35, beats on revenueN/A

About aTyr Pharma, Inc (LIFE):

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its therapeutic candidate pipeline includes ATYR1923, a fusion protein comprising the immuno-modulatory domain of histidyl tRNA synthetase fused of a human antibody that is in Phase 1b/2a clinical trial. The company has a collaboration with the University of Nebraska Medical Center for the development of NRP2 biology; research collaboration and option agreement with CSL Behring for the development of product candidates derived from up to four tRNA synthetases; and research collaboration with Boston Children's Hospital. It also has license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of ATYR1923 for ILDs in Japan; and a research collaboration with the Medical University of South Carolina to develop therapeutic antibodies that selectively target specific NRP2 isoforms. The company was founded in 2005 and is headquartered in San Diego, California.

LIFE Quotes by TradingView

See Advanced Chart

General

  • Name aTyr Pharma, Inc
  • Symbol LIFE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 39
  • Last Split Factor1:14
  • Last Split Date2019-07-01
  • Fiscal Year EndDecember
  • IPO Date2015-05-07
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.atyrpharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 4.89
  • Price/Book (Most Recent Quarter) 1.78
  • Enterprise Value Revenue 3.1
  • Enterprise Value EBITDA 0.01
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.69
  • Profit Margin -202%
  • Operating Margin -198%
  • Return on Assets -25%
  • Return on Equity -59%
  • Revenue 8.55 million
  • Earnings Per Share -$10.21
  • Revenue Per Share $1.15
  • Gross Profit -13626000
  • Quarterly Earnings Growth -19.6%
View More

Highlights

  • Market Capitalization 53.58 million
  • EBITDA -23464000
  • PE Ratio -2.37
  • Analyst Target Price $15
  • Book Value Per Share $3.22
View More

Share Statistics

  • Shares Outstanding 10.19 million
  • Shares Float 8.42 million
  • % Held by Insiders 525%
  • % Held by Institutions 64.57%
  • Shares Short 297643
  • Shares Short Prior Month 159766
  • Short Ratio 0.17
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 2.02
  • 52 Week High $7.93
  • 52 Week Low $2.4
  • 50 Day Moving Average 5
  • 200 Day Moving Average 4.07
View More

Dividends

  • Dividend Date 2019-07-01
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

aTyr Pharma, Inc (LIFE) Dividend Calendar:

LIFE's last dividend payment was made to shareholders on July 1, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

aTyr Pharma, Inc (LIFE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-12$148000-$0.68-$0.748.52%
2020-06-302020-08-13$N/A-$0.69-$0.735.48%
2020-03-312020-05-12$8.07 million$0.25-$0.18238.89%
2019-12-312020-03-26$144000-$1.54-$1.48-4.05%
2019-09-302019-11-14$184000-$1.47-$1.7314.87%
2019-06-302019-08-14$94000-$1.80-$2.7434.35%
2019-03-312019-05-13$N/A-$2.52-$3.1720.5%
2018-12-312019-03-25$N/A-$2.94-$3.4214.04%
2018-09-302018-11-13$N/A-$3.36-$4.0617.24%
2018-06-302018-08-14$N/A-$4.90-$4.69-4.48%
2018-03-312018-05-14$N/A-$5.04-$4.93-2.33%
2017-12-312018-03-19$N/A-$5.46-$5.785.57%
2017-09-302017-11-14$N/A-$6.02-$7.1315.58%
2017-06-302017-08-14$N/A-$7.14-$8.0210.95%
2017-03-312017-05-11$N/A-$7.84-$7.29-7.61%
2016-12-312017-03-16$N/A-$7.42-$8.7415.09%
2016-09-302016-11-14$N/A-$8.12-$9.5514.95%
2016-06-302016-08-10$N/A-$9.10-$9.786.97%
2016-03-312016-05-11$N/A-$9.52-$10.368.11%
2015-12-312016-03-30$N/A-$9.80-$7.85-24.8%
2015-09-302015-11-10$N/A-$0.48-$0.480%
2015-06-302015-08-12$N/A-$0.74-$0.53-39.62%
2015-03-312015-05-12$N/A-$9.39-$0.41-2190.24%

aTyr Pharma, Inc (LIFE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

aTyr Pharma, Inc (LIFE) Chart:

aTyr Pharma, Inc (LIFE) News:

Below you will find a list of latest news for aTyr Pharma, Inc (LIFE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

aTyr Pharma, Inc (LIFE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest LIFE Trades:

Date Shares Price
Jun 13, 2022 7:47 PM EST20$2.635
Jun 13, 2022 7:55 PM EST100$2.67
Jun 13, 2022 7:57 PM EST100$2.68
Jun 13, 2022 7:59 PM EST12$2.67
Jun 13, 2022 7:59 PM EST100$2.69

aTyr Pharma, Inc (LIFE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120038468/0001209191-20-038468-index.htm
2020-09-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1339970/000000000020009034/0000000000-20-009034-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1339970/000031506620000790/0000315066-20-000790-index.htm
2014-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1073431/000090514814000228/0000905148-14-000228-index.htm
2014-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1073431/000093247114003938/0000932471-14-003938-index.htm
2014-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1073431/000101143814000161/0001011438-14-000161-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1339970/000103738920000062/0001037389-20-000062-index.htm
2014-01-29SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1073431/000108636414001133/0001086364-14-001133-index.htm
2014-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1073431/000110465914010587/0001104659-14-010587-index.htm
2013-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm
2013-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760213018757/0001127602-13-018757-index.htm
2013-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760213021773/0001127602-13-021773-index.htm
2013-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760213024305/0001127602-13-024305-index.htm
2013-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760213026615/0001127602-13-026615-index.htm
2013-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760213028325/0001127602-13-028325-index.htm
2013-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760213035342/0001127602-13-035342-index.htm
2014-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214001413/0001127602-14-001413-index.htm
2014-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214001418/0001127602-14-001418-index.htm
2014-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214001650/0001127602-14-001650-index.htm
2014-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214001652/0001127602-14-001652-index.htm
2014-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214001654/0001127602-14-001654-index.htm
2014-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214001656/0001127602-14-001656-index.htm
2014-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214001658/0001127602-14-001658-index.htm
2014-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214001660/0001127602-14-001660-index.htm
2014-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214002547/0001127602-14-002547-index.htm
2014-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214002551/0001127602-14-002551-index.htm
2014-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214002554/0001127602-14-002554-index.htm
2014-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214002558/0001127602-14-002558-index.htm
2014-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214002560/0001127602-14-002560-index.htm
2014-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214002562/0001127602-14-002562-index.htm
2014-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214002564/0001127602-14-002564-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004235/0001127602-14-004235-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004240/0001127602-14-004240-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004246/0001127602-14-004246-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004253/0001127602-14-004253-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004258/0001127602-14-004258-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004261/0001127602-14-004261-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004263/0001127602-14-004263-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004265/0001127602-14-004265-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004267/0001127602-14-004267-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004270/0001127602-14-004270-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004273/0001127602-14-004273-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004275/0001127602-14-004275-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004279/0001127602-14-004279-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004282/0001127602-14-004282-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004289/0001127602-14-004289-index.htm
2014-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1073431/000112760214004295/0001127602-14-004295-index.htm
2013-06-06DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1073431/000119312513250204/0001193125-13-250204-index.htm
2013-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1073431/000119312513251895/0001193125-13-251895-index.htm
2013-06-07DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1073431/000119312513251896/0001193125-13-251896-index.htm
2013-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1073431/000119312513271151/0001193125-13-271151-index.htm
2013-07-22DEFM14ADefinitive proxy statement relating to merger or acquisitionhttps://www.sec.gov/Archives/edgar/data/1073431/000119312513297289/0001193125-13-297289-index.htm
2013-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1073431/000119312513297368/0001193125-13-297368-index.htm
2013-07-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1073431/000119312513297369/0001193125-13-297369-index.htm
2013-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1073431/000119312513312534/0001193125-13-312534-index.htm
2013-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1073431/000119312513315192/0001193125-13-315192-index.htm
2013-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1073431/000119312513342205/0001193125-13-342205-index.htm
2013-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1073431/000119312513427700/0001193125-13-427700-index.htm
2013-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1073431/000119312513427932/0001193125-13-427932-index.htm
2014-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033495/0001193125-14-033495-index.htm
2014-02-04POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033500/0001193125-14-033500-index.htm
2014-02-04POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033506/0001193125-14-033506-index.htm
2014-02-04POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033509/0001193125-14-033509-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033511/0001193125-14-033511-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033512/0001193125-14-033512-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033513/0001193125-14-033513-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033514/0001193125-14-033514-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033518/0001193125-14-033518-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033519/0001193125-14-033519-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033520/0001193125-14-033520-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033521/0001193125-14-033521-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033522/0001193125-14-033522-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033527/0001193125-14-033527-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033533/0001193125-14-033533-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033534/0001193125-14-033534-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033549/0001193125-14-033549-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033561/0001193125-14-033561-index.htm
2014-02-04S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1073431/000119312514033570/0001193125-14-033570-index.htm
2014-02-0415-15DSuspension of duty to report [Section 13 and 15(d)]https://www.sec.gov/Archives/edgar/data/1073431/000119312514034909/0001193125-14-034909-index.htm
2014-02-1415-12GSecurities registration termination [Section 12(g)]https://www.sec.gov/Archives/edgar/data/1073431/000119312514054733/0001193125-14-054733-index.htm
2020-01-27S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1339970/000119312520014827/0001193125-20-014827-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120007710/0001209191-20-007710-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120007716/0001209191-20-007716-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120007719/0001209191-20-007719-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120008205/0001209191-20-008205-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120027949/0001209191-20-027949-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120027960/0001209191-20-027960-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120027966/0001209191-20-027966-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120027974/0001209191-20-027974-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120027984/0001209191-20-027984-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120027995/0001209191-20-027995-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120031886/0001209191-20-031886-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120032780/0001209191-20-032780-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120032784/0001209191-20-032784-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120032794/0001209191-20-032794-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120038463/0001209191-20-038463-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120038468/0001209191-20-038468-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120048698/0001209191-20-048698-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1339970/000120919120049578/0001209191-20-049578-index.htm
2014-02-0425-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1073431/000135445714000015/0001354457-14-000015-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1339970/000138713120001285/0001387131-20-001285-index.htm
2020-02-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1339970/000138713120001876/0001387131-20-001876-index.htm
2014-02-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1073431/000151905814000088/0001519058-14-000088-index.htm
2015-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1073431/000151905815000016/0001519058-15-000016-index.htm
2020-02-03S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1339970/000156459020002994/0001564590-20-002994-index.htm
2020-02-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1339970/000156459020002995/0001564590-20-002995-index.htm
2020-02-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1339970/000156459020002996/0001564590-20-002996-index.htm
2020-02-05S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1339970/000156459020003559/0001564590-20-003559-index.htm
2020-02-06POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1339970/000156459020003561/0001564590-20-003561-index.htm
2020-02-06424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1339970/000156459020003745/0001564590-20-003745-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1339970/000156459020004724/0001564590-20-004724-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1339970/000156459020007842/0001564590-20-007842-index.htm
2020-03-18PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1339970/000156459020011637/0001564590-20-011637-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1339970/000156459020013193/0001564590-20-013193-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1339970/000156459020013208/0001564590-20-013208-index.htm
2020-04-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1339970/000156459020014976/0001564590-20-014976-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1339970/000156459020017579/0001564590-20-017579-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1339970/000156459020023612/0001564590-20-023612-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1339970/000156459020024718/0001564590-20-024718-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1339970/000156459020024729/0001564590-20-024729-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1339970/000156459020025993/0001564590-20-025993-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1339970/000156459020026381/0001564590-20-026381-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1339970/000156459020026385/0001564590-20-026385-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1339970/000156459020030026/0001564590-20-030026-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1339970/000156459020040004/0001564590-20-040004-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1339970/000156459020040057/0001564590-20-040057-index.htm
2020-08-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1339970/000156459020040458/0001564590-20-040458-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1339970/000156459020043349/0001564590-20-043349-index.htm
2020-09-18S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1339970/000156459020044008/0001564590-20-044008-index.htm
2020-09-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1339970/000156459020044550/0001564590-20-044550-index.htm
2020-10-02424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1339970/000156459020045765/0001564590-20-045765-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1339970/000162363220000257/0001623632-20-000257-index.htm
2014-02-04EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1073431/999999999514000318/9999999995-14-000318-index.htm
2020-02-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1339970/999999999520000261/9999999995-20-000261-index.htm
2020-09-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1339970/999999999520002595/9999999995-20-002595-index.htm

aTyr Pharma, Inc (LIFE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of aTyr Pharma, Inc (LIFE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 525%
Institutional Ownership: 6457%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2014-02-03BALAKRISHNAN S IYERDirectorSell8,888.0076.13676,654.110.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004253/0001127602-14-004253-index.htm
2014-02-03DAVID C UPRICHARDDirectorSell2,930.0076.13223,064.420.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004267/0001127602-14-004267-index.htm
2014-02-03David F HoffmeisterChief Financial OfficerSell84,804.0076.136,456,230.280.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004275/0001127602-14-004275-index.htm
2014-02-03GEORGE F JR ADAMDirectorSell2,747.0076.13209,132.410.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004235/0001127602-14-004235-index.htm
2014-02-03GREGORY T LUCIERChief Executive OfficerSell456,046.0076.1334,719,329.240.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004282/0001127602-14-004282-index.htm
2014-02-03JOHN A COTTINGHAMChief Legal OfficerSell8,231.0076.13626,635.910.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004273/0001127602-14-004273-index.htm
2014-02-03KELLI RICHARDChief Accounting OfficerSell5,191.3476.13395,222.940.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004289/0001127602-14-004289-index.htm
2014-02-03Mark StevensonPresident & COOSell122,923.0076.139,358,275.500.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004295/0001127602-14-004295-index.htm
2014-02-03Ora H. PescovitzDirectorSell5,451.0076.13414,991.170.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004265/0001127602-14-004265-index.htm
2014-02-03Peter Michael LeddySVP, Global Human ResourcesSell41,475.0076.133,157,541.520.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004279/0001127602-14-004279-index.htm
2014-02-03RAYMOND V DITTAMOREDirectorSell23,073.0076.131,756,575.180.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004240/0001127602-14-004240-index.htm
2014-02-03RONALD A MATRICARIADirectorSell70,000.0076.135,329,184.000.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004258/0001127602-14-004258-index.htm
2014-02-03RONALD ASBURY ANDREWSPresident, Medical SciencesSell7,357.0076.13560,097.240.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004270/0001127602-14-004270-index.htm
2020-09-02JOHN K CLARKEDirectorSell7,260.004.0129,112.60110,583.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120049578/0001209191-20-049578-index.htm
2020-08-28JOHN K CLARKEDirectorSell100.004.00400.00117,843.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120049578/0001209191-20-049578-index.htm
2020-08-27JOHN K CLARKEDirectorSell5,440.004.0922,249.60117,943.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120048698/0001209191-20-048698-index.htm
2014-01-07JOHN A COTTINGHAMChief Legal OfficerBuy9,956.4875.85755,199.0112,232.30https://www.sec.gov/Archives/edgar/data/1073431/000112760214001660/0001127602-14-001660-index.htm
2020-08-26JOHN K CLARKEDirectorSell2,200.004.309,451.20123,383.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120048698/0001209191-20-048698-index.htm
2020-02-07Sanjay ShuklaPresident and CEOSell745.004.033,002.351,291.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120007719/0001209191-20-007719-index.htm
2013-08-01KELLI RICHARDChief Accounting OfficerBuy1,726.0074.78129,070.2813,480.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213024305/0001127602-13-024305-index.htm
2013-12-18Mark StevensonPresident & COOBuy76,000.0022.231,689,480.00173,260.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213035342/0001127602-13-035342-index.htm
2014-01-07Peter Michael LeddySVP, Global Human ResourcesBuy10,072.4375.85763,993.8218,951.95https://www.sec.gov/Archives/edgar/data/1073431/000112760214001654/0001127602-14-001654-index.htm
2020-02-06Sanjay ShuklaPresident and CEOBuy1,786.002,036.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120007719/0001209191-20-007719-index.htm
2014-01-06RAYMOND V DITTAMOREDirectorSell5,000.0075.86379,300.0023,073.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214001418/0001127602-14-001418-index.htm
2020-05-20NANCY DENYESGeneral CounselSell322.003.621,165.642,735.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120032794/0001209191-20-032794-index.htm
2014-01-07David F HoffmeisterChief Financial OfficerBuy12,022.7875.85911,927.8627,465.93https://www.sec.gov/Archives/edgar/data/1073431/000112760214001650/0001127602-14-001650-index.htm
2013-05-29DAVID C UPRICHARDDirectorSell2,010.0074.04148,820.402,930.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018757/0001127602-13-018757-index.htm
2020-05-16NANCY DENYESGeneral CounselBuy892.003,057.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120032794/0001209191-20-032794-index.htm
2013-05-24JOHN A COTTINGHAMChief Legal OfficerBuy28,362.0030.53865,891.8636,593.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm
2013-05-28JOHN A COTTINGHAMChief Legal OfficerBuy28,362.0030.53865,891.8636,593.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm
2013-09-03Peter Michael LeddySVP, Global Human ResourcesBuy2,404.0074.58179,290.3242,730.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213026615/0001127602-13-026615-index.htm
2020-05-20PAUL SCHIMMELDirectorSell8,447.003.6430,738.63429,143.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120031886/0001209191-20-031886-index.htm
2020-02-10PAUL SCHIMMELDirectorBuy254,000.004.251,079,500.00437,590.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120008205/0001209191-20-008205-index.htm
2014-01-07Mark StevensonPresident & COOBuy19,869.5475.851,507,104.6147,873.96https://www.sec.gov/Archives/edgar/data/1073431/000112760214001652/0001127602-14-001652-index.htm
2014-01-07KELLI RICHARDChief Accounting OfficerBuy5,191.3475.85393,763.145,191.34https://www.sec.gov/Archives/edgar/data/1073431/000112760214001656/0001127602-14-001656-index.htm
2013-07-01Ora H. PescovitzDirectorBuy308.005,451.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213021773/0001127602-13-021773-index.htm
2014-02-03Ora H. PescovitzDirectorSell750.0076.1357,098.405,451.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214004265/0001127602-14-004265-index.htm
2013-10-01Ora H. PescovitzDirectorBuy359.005,810.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213028325/0001127602-13-028325-index.htm
2014-01-03Ora H. PescovitzDirectorBuy391.006,201.00https://www.sec.gov/Archives/edgar/data/1073431/000112760214001413/0001127602-14-001413-index.htm
2020-02-07Jill Marie BroadfootChief Financial OfficerSell375.004.031,511.257,125.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120007710/0001209191-20-007710-index.htm
2020-06-19Sanjay ShuklaPresident and CEOBuy6,000.004.2725,620.007,291.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120038463/0001209191-20-038463-index.htm
2020-02-06Jill Marie BroadfootChief Financial OfficerBuy893.007,500.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120007710/0001209191-20-007710-index.htm
2014-01-07GREGORY T LUCIERChief Executive OfficerBuy50,123.6675.853,801,879.6181,071.86https://www.sec.gov/Archives/edgar/data/1073431/000112760214001658/0001127602-14-001658-index.htm
2013-05-24JOHN A COTTINGHAMChief Legal OfficerSell1,638.0073.86120,982.848,231.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm
2013-05-24JOHN A COTTINGHAMChief Legal OfficerSell200.0073.8714,774.008,231.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm
2013-05-28JOHN A COTTINGHAMChief Legal OfficerSell28,362.0074.202,104,460.408,231.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm
2013-05-28JOHN A COTTINGHAMChief Legal OfficerSell1,200.0074.2589,094.008,231.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm
2013-05-24JOHN A COTTINGHAMChief Legal OfficerSell28,162.0073.872,080,186.138,431.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm
2020-06-19Jill Marie BroadfootChief Financial OfficerBuy1,850.004.227,807.009,153.00https://www.sec.gov/Archives/edgar/data/1339970/000120919120038468/0001209191-20-038468-index.htm
2013-05-28JOHN A COTTINGHAMChief Legal OfficerSell438.0074.2432,517.169,431.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm
2013-05-24JOHN A COTTINGHAMChief Legal OfficerBuy1,638.0030.5350,008.149,869.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm
2013-05-28JOHN A COTTINGHAMChief Legal OfficerBuy1,638.0030.5350,008.149,869.00https://www.sec.gov/Archives/edgar/data/1073431/000112760213018709/0001127602-13-018709-index.htm